From: Feasibility analysis of combined surgery for esophageal cancer
Characteristic | Univariate | Multivariable | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Operation | ||||||
 SEC | 1 |  |  |  |  |  |
 COEC | 0.862 | 0.487–1.525 | 0.609 |  |  |  |
Age | 1.008 | 0.992–1.025 | 0.312 |  |  |  |
Sex | 1.129 | 0.855–1.492 | 0.392 |  |  |  |
BMI | 0.973 | 0.937–1.010 | 0.146 |  |  |  |
Smoking | 1.062 | 0.821–1.373 | 0.646 |  |  |  |
Drinking | 1.161 | 0.873–1.545 | 0.305 |  |  |  |
Lung disease | 1.073 | 0.653–1.762 | 0.782 |  |  |  |
Diabetes | 1.702 | 1.127–2.571 | 0.011* | 1.604 | 1.049–2.454 | 0.029* |
Hypertension | 0.978 | 0.731–1.307 | 0.878 |  |  |  |
Coronary heart disease | 1.741 | 1.117–2.712 | 0.014* | 1.592 | 1.008–2.515 | 0.046* |
FVC | 0.862 | 0.735–1.010 | 0.067 |  |  |  |
FEV1 | 0.854 | 0.703–1.037 | 0.111 |  |  |  |
DLCO | 0.894 | 0.830–0.964 | 0.003* | 0.916 | 0.849–0.988 | 0.024* |
EF | 0.970 | 0.917–1.026 | 0.284 |  |  |  |
WBC | 0.998 | 0.940–1.060 | 0.956 |  |  |  |
ALB | 0.950 | 0.919–0.981 | 0.002* | 0.955 | 0.924–0.987 | 0.007* |
N | 0.994 | 0.948–1.043 | 0.810 |  |  |  |
LN | 0.938 | 0.813–1.082 | 0.381 |  |  |  |
M | 0.961 | 0.793–1.165 | 0.685 |  |  |  |
Tumor location | ||||||
 Upper | 1 |  |  |  |  |  |
 Middle | 0.968 | 0.660–1.420 | 0.866 |  |  |  |
 Lower | 0.809 | 0.556–1.176 | 0.266 |  |  |  |
 GEJ | 0.513 | 0.288–0.914 | 0.023* | - | - | - |
Histological type | ||||||
 Squamous | 1 |  |  |  |  |  |
 Adenocarcinoma | 0.637 | 0.415–0.977 | 0.039* | - | - | - |
 Other | 0.977 | 0.581–1.645 | 0.931 |  |  |  |
Tumor size (cm) | 0.988 | 0.908–1.073 | 0.768 |  |  |  |
TNM stage | ||||||
 1 |  |  |  |  |  |  |
 2 | 0.911 | 0.671–1.237 | 0.550 |  |  |  |
 3 | 0.914 | 0.663–1.260 | 0.583 |  |  |  |
 4 | 0.791 | 0.419–1.491 | 0.468 |  |  |  |
Operation time | 1.003 | 1.001–1.006 | 0.009* | - | - | - |
Intraoperative infusion | 1.000 | 1.000–1.001 | 0.005* | - | - | - |
Surgical procedures | 0.695 | 0.464–1.040 | 0.077 |  |  |  |